TRANSACTIONS
Recent Selected Transactions
2022 : TechnoConcept secures 4.4M€ financing and secondary buy-out
2022 : Harmony Biosciences acquires Bioprojet’s Wakix XR US licensing rights
2021 : Novadip 21M€ series B1 financing
2021 : Robocath secures 15M€ financing with EIB
2020 : Robocath 40M€ series C financing
2020 : European Licensing-out Advisory for Catabasis Pharmaceuticals
2019 : Beaver Visitec acquires Arcadophta
2019 : FineHeart 5M€ bridge financing
2019 : Senior Assist 20M€ growth financing
2018 : Endo-Pharmaceuticals acquires Bioprojet’s Wakix commercial rights in Canada
2018 : Licensing-out Advisory for Acteon
2017 : Harmony Biosciences acquires Bioprojet’s Wakix commercial rights in the US
2016 : AFM Telethon sells Trophos’ Olesoxime commercial rights to Roche Pharmaceuticals
Bionest Partners Finance has performed an extensive number of Financial Advisory projects for Healthtech startups and specialty Pharma companies (fairness opinion, business plan, deal structuring).